Research portfolio

Research portfolio


From cause to cure

NA-infographic-2015

The service-offering propositions of the Industry Alliance Office consist of the bundling and integration of several commercial research services, based on five main stream brain disease research programs:

Neurodegeneration
Alzheimer’s, frontotemporal dementia and Parkinson’s Disease
Neuroinfection & -inflammation
Multiple Sclerosis, Meningitis and Chronic Inflammatory Demyelinating Polyneuropathy
Neurovascular Disorders
Cerebral Vascular Accident
Neuropsychiatry
Compulsivity, Impulsivity and Attention
Neuropsychiatry
Mood, Anxiety and Psychosis (including Schizophrenia)

Identified research themes and related research activities are supported by specific expertise teams and technology platforms, including those of the following research programs: Brain Imaging, Complex Trait Genetics, Neurotechnology (including new design of Deep Brain Stimulation but also optogenetics) and Brain Mechanisms (including all omics, cell and animal model work).

Finding the cause and designing the cure

The words molecules, genes, synaptic transmission and brain connectivity are the buzzwords for many of our innovations in the field of neurology and neuropsychiatry. Also all the latest insights in neuroinflammation and neurodegenerative mechanisms in Multiple Sclerosis are traditionally mainstream research objectives. However, through the launch of Amsterdam Neuroscience we now also have strong translational ambitions for the fields of neuroinfection (Meningitis, Chronic Inflammatory Demyelinating Polyneuropathy, i.e. CIDP), neurovascular disorders (CVA) and a variety of other behavioral disorders such OCD, Schizophrenia and psychosis. These interests provide a strong translational link between neurology of aging diseases and molecular and cellular neurobiology. Between psychiatry and behavioral and clinical genetics, and between psychology and biostatistics.

We focus on the biological mechanisms underlying common mental health and neurological brain diseases. We apply the latest technology including pharma and/or immunotherapy, deep brain stimulation and neurosurgery and thereby provide new perspectives on therapy. Finding the ‘cause’ of brain diseases, design its ‘cure’ and implement this to the level of ‘patient care’ are all in the center of our research ambition